The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | S | Sensory organs | |
| 2 | S01 | Ophthalmologicals | |
| 3 | S01B | Antiinflammatory agents | |
| 4 | S01BA | Corticosteroids, plain | |
| 5 | S01BA14 | Loteprednol |
| Active Ingredient | Description | |
|---|---|---|
| Loteprednol |
Loteprednol etabonate is a new class of corticosteroid with potent antiinflammatory activity designed to be active at the site of action. Its antiinflammatory activity is similar to the most powerful steroid used in ophthalmology but with less intraocular pressure. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ALREX Ophthalmic suspension | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| LOTEMAX Eye-drops, suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
